Skip to main content

Not much in common

A comparison of the Celera and Ensembl transcriptomes examines how many predicted genes they have in common.

Written byJonathan Weitzman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

The two groups who sequenced the human genome agreed on one thing – that there are fewer genes than everyone originally thought. Both groups estimated around 30,000 genes, using un-precise prediction methods. In the August 24 Cell, John Hogenesch and colleagues, at The Genomics Institute of the Novartis Research Foundation in California, compared the two sets of predicted genes to see how much they agree (Cell 2001, 106:413-415).

They compared the transcriptomes of the Celera (39,114 genes) and Ensembl (29,691 genes) draft sequences with each other, and with the curated Refseq set of genes. First, they showed that the Celera and Ensembl sets contained most of the known genes. But, of the 31,098 potential novel transcripts, 80% were predicted by only one group or the other, but not both. Hogenesch et al. then performed oligonucleotide microarray analysis to examine the expression profile of these potential novel transcripts.

They found that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays